Literature DB >> 34060143

Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents.

Mumtaz A Munshi1, Megan H Noe2, Yvonne E Chiu3, Jenna L Streicher4.   

Abstract

Pediatric dermatologists should be aware of immunization schedules and special recommendations for patients on immunosuppressive agents due to the increased risk of vaccine-preventable infections. Prior to initiating immunosuppressive therapy, pediatric dermatologists should review a vaccine history and administer any necessary age-appropriate or catch-up vaccines. Live vaccines are typically contraindicated while on immunosuppressive therapy, while inactivated vaccines are generally safe to administer.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  immunosuppression; immunosuppressive agents; vaccination; vaccines

Mesh：

Substances：

Year:  2021        PMID： 34060143      PMCID： PMC8578306          DOI： 10.1111/pde.14631

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.997


  24 in total

1.  Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children.

Authors:  H Dele Davies
Journal:  Pediatrics       Date:  2016-07-18       Impact factor: 7.124

2.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.

Authors:  Eric E Mast; Harold S Margolis; Anthony E Fiore; Edward W Brink; Susan T Goldstein; Susan A Wang; Linda A Moyer; Beth P Bell; Miriam J Alter
Journal:  MMWR Recomm Rep       Date:  2005-12-23

3.  The pharmacology of immunosuppression.

Authors:  Martin M Zdanowicz
Journal:  Am J Pharm Educ       Date:  2009-12-17       Impact factor: 2.047

4.  Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.

Authors:  Pablo A Olivera; Juan S Lasa; Stefanos Bonovas; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Gastroenterology       Date:  2020-01-09       Impact factor: 22.682

5.  Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

Authors:  M C Kapetanovic; T Saxne; A Sjöholm; L Truedsson; G Jönsson; P Geborek
Journal:  Rheumatology (Oxford)       Date:  2005-11-15       Impact factor: 7.580

6.  Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.

Authors:  Jonathan Moses; Naim Alkhouri; Angela Shannon; Kathy Raig; Rocio Lopez; Lara Danziger-Isakov; Ariel E Feldstein; Nizar N Zein; Robert Wyllie; Christine Carter-Kent
Journal:  Am J Gastroenterol       Date:  2011-08-30       Impact factor: 10.864

7.  Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  J Pekka Nuorti; Cynthia G Whitney
Journal:  MMWR Recomm Rep       Date:  2010-12-10

Review 8.  Mechanisms of action of methotrexate.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Bull Hosp Jt Dis (2013)       Date:  2013

9.  The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis.

Authors:  Kevin L Winthrop; Joel Silverfield; Arthur Racewicz; Jeffrey Neal; Eun Bong Lee; Pawel Hrycaj; Juan Gomez-Reino; Koshika Soma; Charles Mebus; Bethanie Wilkinson; Jennifer Hodge; Haiyun Fan; Tao Wang; Clifton O Bingham
Journal:  Ann Rheum Dis       Date:  2015-03-20       Impact factor: 19.103

10.  Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.

Authors:  Lawrence F Eichenfield; Thomas Bieber; Lisa A Beck; Eric L Simpson; Diamant Thaçi; Marjolein de Bruin-Weller; Mette Deleuran; Jonathan I Silverberg; Carlos Ferrandiz; Regina Fölster-Holst; Zhen Chen; Neil M H Graham; Gianluca Pirozzi; Bolanle Akinlade; George D Yancopoulos; Marius Ardeleanu
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.